These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19623719)
1. [Etiology of acute enteric infection in children with arid zone and effect of probiotics]. Utemuradova GE Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):98-100. PubMed ID: 19623719 [TBL] [Abstract][Full Text] [Related]
2. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections]. Korviakova EP Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639 [TBL] [Abstract][Full Text] [Related]
3. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte]. Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264 [TBL] [Abstract][Full Text] [Related]
4. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics]. Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202 [TBL] [Abstract][Full Text] [Related]
5. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes]. Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566 [TBL] [Abstract][Full Text] [Related]
6. [The use of sporulating bacteria in treating patients with dysbacteriosis]. Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782 [TBL] [Abstract][Full Text] [Related]
7. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement]. Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980 [TBL] [Abstract][Full Text] [Related]
8. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte]. Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396 [TBL] [Abstract][Full Text] [Related]
9. [Study of the effectiveness of biological antagonist preparations in intestinal infections in children]. Avanesova AG; Lazareva NA; Ruzaikina NI; D'iakova EI; Kurnosova NA Vopr Okhr Materin Det; 1973 Jul; 18(7):39-43. PubMed ID: 4762308 [No Abstract] [Full Text] [Related]
10. [The regulation of microecological disorders of the intestines in newborn infants with perinatal pathology using the new probiotic bifidumbacterin-forte]. Iakushenko MN; Tkhagapsoeva ZhM; Bondarenko VM Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):18-22. PubMed ID: 9460858 [TBL] [Abstract][Full Text] [Related]
11. [Effect of colibacterin on the excretion of bacteria in children with dysentery]. Skirda GI Pediatriia; 1974; 53(5):66-8. PubMed ID: 4603499 [No Abstract] [Full Text] [Related]
12. [The need for revision of the bacteriological criteria of the etiological significance of diarrheogenic Escherichia strains in the diagnosis of acute intestinal infections]. Ulisko IN; Baturo AP; Romanenko EE; Stepanova MV; Ratiner IuA Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):7-10. PubMed ID: 9103082 [TBL] [Abstract][Full Text] [Related]
13. Identification of enteric pathogens in the small and large intestine of children with diarrhea. Echeverria P; Taylor DN; Leksomboon U; Blacklow NR; Pinnoi S; Nataro JP; Kaper J; Rowe B Diagn Microbiol Infect Dis; 1986 Apr; 4(4):277-84. PubMed ID: 3516549 [TBL] [Abstract][Full Text] [Related]
14. [Use of bifidumbacterin in young children with acute intestinal diseases]. Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947 [No Abstract] [Full Text] [Related]
15. [Experience in using streptomycin-resistant colibacterin in treating chronic Sonne dysentery in children]. Petrichenko VG; Ozerianskaia NM Pediatriia; 1974; 53(5):72. PubMed ID: 4603529 [No Abstract] [Full Text] [Related]
16. Successful treatment of enterohemorrhagic Escherichia coli O111-induced acute encephalopathy and hemolytic-uremic syndrome with plasma diafiltration. Shimizu M; Nakayama Y; Taniguchi T Ther Apher Dial; 2014 Oct; 18(5):516-8. PubMed ID: 24467800 [No Abstract] [Full Text] [Related]
17. Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter. Bodhidatta L; Vithayasai N; Eimpokalarp B; Pitarangsi C; Serichantalergs O; Isenbarger DW Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):752-7. PubMed ID: 12757222 [TBL] [Abstract][Full Text] [Related]
18. [Study of the properties of E. coli of serological group 03 isolated in acute intestinal diseases]. Belaia OS; Sutulova AA Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):129-33. PubMed ID: 354285 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome]. Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070 [TBL] [Abstract][Full Text] [Related]
20. Virulence genes profiles and phylogenetic origin of Escherichia coli from acute and chronic intestinal diseases revealed by comparative genomic hybridization microarray. Sobieszczańska B; Kasprzykowska U; Turniak M; Maciejewski H; Franiczek R; Duda-Madej A Pol J Microbiol; 2012; 61(2):105-10. PubMed ID: 23163209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]